Number of the records: 1
Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma
Title Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma Author Cholujová Dana 1975- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Co-authors Lukáčová Bujňáková Zdenka 1983 SAVGEOTE - Ústav geotechniky SAV ORCID Dutková Erika 1975 SAVGEOTE - Ústav geotechniky SAV ORCID Hideshima Teru Groen Richard W. J. Mitsiades Constantine S. Richardson Paul G. Dorfman David Baláž Peter 1947 SAVGEOTE - Ústav geotechniky SAV Anderson Kenneth C. Jakubíková Jana 1976- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV ORCID Source document British Journal of Haematology. Vol. 179, no. 5 (2017) p. 756-771 Language eng - English Country GB - Great Britian Document kind rozpis článkov z periodík (rbx) Citations HUANG, Mingzhi - CHEN, Hongyan - ZHUANG, Yong - WU, Zhanyu - SHANG, Xianwen. Effects and mechanisms of bortezomib combined with arsenic trioxide on multiple myeloma. In INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE. ISSN 1940-5901, 2019, vol. 12, no. 7, pp. 8388-8394. WANG, Tao - WEN, Tao - LI, Hongmin - HAN, Bing - HAO, Suisui - WANG, Chuan - MA, Qiang - MENG, Jie - LIU, Jian - XU, Haiyan. Arsenic sulfide nanoformulation induces erythroid differentiation in chronic myeloid leukemia cells through degradation of BCR-ABL. In INTERNATIONAL JOURNAL OF NANOMEDICINE. ISSN 1178-2013, 2019, vol. 14, no., pp. 5581-5594. WANG, Tao - MENG, Jie - WANG, Chuan - WEN, Tao - JIA, Mengfan - GE, Yangyang - XIE, Lifei - HAO, Suisui - LIU, Jian - XU, Haiyan. Inhibition of Murine Breast Cancer Metastases by Hydrophilic As4S4 Nanoparticles Is Associated With Decreased ROS and HIF-1 alpha Downregulation. In FRONTIERS IN ONCOLOGY. ISSN 2234-943X, 2019, vol. 9, no., pp. ZHONG, Wenhao - ZHANG, Xinyu - ZHAO, Meng - WU, Jun - LIN, Dongjun. Advancements in nanotechnology for the diagnosis and treatment of multiple myeloma. In BIOMATERIALS SCIENCE. ISSN 2047-4830, 2020, vol. 8, no. 17, pp. 4692-4711. ZHANG, Sujuan - ZHANG, Yongtai - WANG, Zhi - GUO, Teng - HOU, Xuefeng - HE, Zhiyuan - HE, Zehui - SHEN, Lina - FENG, Nianping. Temperature-sensitive gel-loaded composite nanomedicines for the treatment of cervical cancer by vaginal delivery. In INTERNATIONAL JOURNAL OF PHARMACEUTICS. ISSN 0378-5173, 2020, vol. 586, no., pp. SUN, Yu Ting - XU, Huan Hua - NIE, Yao - WANG, Yu Guang - MA, Zeng Chun - ZHOU, Wei - TAN, Hong Ling - GAO, Yue. Preliminary study of realgar and arsenic trioxide on gut microbiota of mice. In Zhongguo Zhongyao Zazhi. ISSN 10015302, 2020-01-01, 45, 1, pp. 142-148. YOUSEFNIA, Saghar. Mechanistic effects of arsenic trioxide on acute promyelocytic leukemia and other types of leukemias. In CELL BIOLOGY INTERNATIONAL. ISSN 1065-6995, 2021, vol. 45, no. 6, pp. 1148-1157. LIU, Zhengyun - XU, Ke - XU, Yan - ZHANG, Wanling - JIAN, Nian - WANG, Shengyu - LIU, Jie - WU, Jinzhu - LUO, Guo - WANG, Huan. Involvement of autophagy in realgar quantum dots (RQDs) inhibition of human endometrial cancer JEC cells. In PEERJ. ISSN 2167-8359, 2020, vol. 8, no., pp. IANNAZZO, Daniela - ETTARI, Roberta - GIOFRE, Salvatore - EID, Ali H. - BITTO, Alessandra. Recent Advances in Nanotherapeutics for Multiple Myeloma. In CANCERS, 2020, vol. 12, no. 11, pp. WANG, X.B. - YUAN, L.H. - YAN, L.P. - YE, Y.B. - LU, B. - XU, X.J. UNC13B Promote Arsenic Trioxide Resistance in Chronic Lymphoid Leukemia Through Mitochondria Quality Control. In FRONTIERS IN ONCOLOGY. ISSN 2234-943X, MAY 30 2022, vol. 12. Dostupné na: https://doi.org/10.3389/fonc.2022.920999. SHI, D.S. - PU, S.Y. - YIN, H.T. - SONG, Y.Y. - LIU, H.M. - YU, X.L. - ZHAO, Y. - YE, C.K. - LIU, S.Y. - WANG, X.Q. - HUANG, J.J. - ZHANG, Y. - XIE, J. Fluorescent Realgar Nanoclusters for Nuclear Targeting-Triggered Tumor Theranostics. In ACS APPLIED NANO MATERIALS. MAY 27 2022, vol. 5, no. 5, p. 6485-6499. Dostupné na: https://doi.org/10.1021/acsanm.2c00577. YU, M.Z. - ZHANG, Y.W. - FANG, M.R. - JEHAN, S. - ZHOU, W.H. Current Advances of Nanomedicines Delivering Arsenic Trioxide for Enhanced Tumor Therapy. In PHARMACEUTICS. APR 2022, vol. 14, no. 4. Dostupné na: https://doi.org/10.3390/pharmaceutics14040743. PAUL, N.P. - GALVAN, A.E. - YOSHINAGA-SAKURAI, K. - ROSEN, B.P. - YOSHINAGA, M. Arsenic in medicine: past, present and future. In BIOMETALS. ISSN 0966-0844, APR 2023, vol. 36, no. 2, SI, p. 283-301. Dostupné na: https://doi.org/10.1007/s10534-022-00371-y. LIAO, W.H. - LI, Y.C. - WANG, J. - ZHAO, M.Y. - CHEN, N.Z. - ZHENG, Q. - WAN, L.N. - MOU, Y. - TANG, J.Y. - WANG, Z.L. Natural Products-Based Nanoformulations: A New Approach Targeting CSCs to Cancer Therapy. In INTERNATIONAL JOURNAL OF NANOMEDICINE. ISSN 1178-2013, 2022, vol. 17, p. 4163-4193. Dostupné na: https://doi.org/10.2147/IJN.S380697. Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2017 Registered in WOS Registered in SCOPUS Registered in CCC DOI 10.1111/bjh.14974 
article
File name Access Size Downloaded Type License Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma.pdf available 1.3 MB 6 Publisher's version rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2017 2016 5.670 Q1 2.086 Q1
Number of the records: 1